NCT00654758 2017-11-21
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Phase 1 Completed
Clinical Trials
9 trialsNCT00278187 2013-12-19
Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00401570 2013-01-30
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer
AbbVie
Phase 2 Completed
NCT00635193 2013-01-18
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
AbbVie
Phase 1/2 Completed
NCT00516841 2012-08-23
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Facet Biotech
Phase 2 Terminated
NCT00100685 2012-04-27
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
Abbott
Phase 2 Terminated
NCT00369395 2012-04-27
A Study of Volociximab in Metastatic Melanoma
Abbott
Phase 2 Terminated
NCT00666692 2012-04-27
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
Abbott
Phase 1 Completed
NCT00099970 2008-08-05
Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy
Facet Biotech
Phase 2 Completed